| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Listeria-based vaccine targeting ISG15 exerts anti-tumor efficacy in renal cell carcinoma
|
Nguyen, Hong-My
|
|
|
72 |
9 |
p. 2889-2903
|
artikel
|
| 2 |
A Novel bispecific T-cell engager (BiTE) targeting CD22 and CD3 has both in vitro and in vivo activity and synergizes with blinatumomab in an acute lymphoblastic leukemia (ALL) tumor model
|
Meckler, Joshua F.
|
|
|
72 |
9 |
p. 2939-2948
|
artikel
|
| 3 |
Characterization of human Fc alpha receptor transgenic mice: comparison of CD89 expression and antibody-dependent tumor killing between mouse strains
|
Stip, Marjolein C.
|
|
|
72 |
9 |
p. 3063-3077
|
artikel
|
| 4 |
Considerations regarding the tumor-suppressor role of naringenin as a novel agent for the treatment of oral squamous cell carcinoma
|
Li, Chen-xi
|
|
|
72 |
9 |
p. 3133-3134
|
artikel
|
| 5 |
Efficacy and safety of geptanolimab (GB226) for relapsed/refractory primary mediastinal large B-cell lymphoma: an open-label phase II study (Gxplore-003)
|
Shi, Yuankai
|
|
|
72 |
9 |
p. 2991-3002
|
artikel
|
| 6 |
Efficacy, safety, and prognostic factors of PD-1 inhibitors combined with lenvatinib and Gemox chemotherapy as first-line treatment in advanced intrahepatic cholangiocarcinoma: a multicenter real-world study
|
Zhu, Chengpei
|
|
|
72 |
9 |
p. 2949-2960
|
artikel
|
| 7 |
Engineered soluble, trimerized 4-1BBL variants as potent immunomodulatory agents
|
Battin, Claire
|
|
|
72 |
9 |
p. 3029-3043
|
artikel
|
| 8 |
IL-36α inhibits melanoma by inducing pro-inflammatory polarization of macrophages
|
Lou, Xinyi
|
|
|
72 |
9 |
p. 3045-3061
|
artikel
|
| 9 |
Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancer
|
Egelston, Colt A.
|
|
|
72 |
9 |
p. 3013-3027
|
artikel
|
| 10 |
Multivalent adaptor proteins specifically target NK cells carrying a universal chimeric antigen receptor to ErbB2 (HER2)-expressing cancers
|
Pfeifer Serrahima, Jordi
|
|
|
72 |
9 |
p. 2905-2918
|
artikel
|
| 11 |
Murine regulatory T cells utilize granzyme B to promote tumor metastasis
|
Tibbs, Ellis
|
|
|
72 |
9 |
p. 2927-2937
|
artikel
|
| 12 |
NLRP3 agonist enhances radiation-induced immune priming and promotes abscopal responses in anti-PD1 resistant model
|
Barsoumian, Hampartsoum B.
|
|
|
72 |
9 |
p. 3003-3012
|
artikel
|
| 13 |
Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study
|
Santoni, Matteo
|
|
|
72 |
9 |
p. 2961-2970
|
artikel
|
| 14 |
Spatiotemporal commonality of the TCR repertoire in a T-cell memory murine model and in metastatic human colorectal cancer
|
Haraguchi, Mizuki
|
|
|
72 |
9 |
p. 2971-2989
|
artikel
|
| 15 |
TGF-β1 mediates tumor immunosuppression aggravating at the late stage post-high-light-dose photodynamic therapy
|
Han, Lingfei
|
|
|
72 |
9 |
p. 3079-3095
|
artikel
|
| 16 |
Therapeutic potential of FLT4-targeting peptide in acute myeloid leukemia
|
Lee, Ji Yoon
|
|
|
72 |
9 |
p. 2919-2925
|
artikel
|
| 17 |
The RIG-I agonist M8 triggers cell death and natural killer cell activation in human papillomavirus-associated cancer and potentiates cisplatin cytotoxicity
|
Girone, Carlo
|
|
|
72 |
9 |
p. 3097-3110
|
artikel
|
| 18 |
The TSP1-CD47-SIRPα interactome: an immune triangle for the checkpoint era
|
Montero, Enrique
|
|
|
72 |
9 |
p. 2879-2888
|
artikel
|
| 19 |
Tumor immunology meets oncology (TIMO) XVI, July 07–09 2022 in Halle/Saale, Germany
|
Seliger, Barbara
|
|
|
72 |
9 |
p. 3125-3132
|
artikel
|
| 20 |
Unbiased chemokine receptor screening reveals similar efficacy of lymph node- and tumor-targeted T cell immunotherapy
|
Pachmayr, Ludwig O.
|
|
|
72 |
9 |
p. 3111-3124
|
artikel
|
Tijdschrift beschrijving